The why and how of adaptive immune responses in ischemic cardiovascular disease. (2022)

First Author: Mallat Z
Attributed to:  Low dose interleukin (IL)-2 in patients with a recent acute coronary syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.83126

Publication URI: https://www.repository.cam.ac.uk/handle/1810/335690

Type: Journal Article/Review